76results about How to "Take effect quickly" patented technology

The invention provides a domain name resolution system and a domain name resolution method that are used for attaining an aim of making a domain name configuration file be rapidly effective. The domain name resolution system comprises a management module, a conversion module, a data center and a serve, wherein the management module is used for managing corresponding relations between domain names and IP addresses and storing the corresponding relations in the management module in a sorted manner, the conversion module is used for converting each corresponding relation into a configuration file that can be identified by a server and sending each configuration file to the data center, the data center is used for storing the configuration file, and the server is used for storing the configuration file stored in the data center in the server; when a domain name resolution request sent via a client end is received, a configuration file corresponding to a domain name requested via the client end is read from the server according to the domain name requested via the client end, an IP address corresponding to the domain name requested via the client end can be determined according to the configuration file, and an IP address corresponding to the domain name requested via the client end can be fed back to the client end.

The invention discloses a drug for treating osteoporosis, and particularly relates to an oral dripping pill preparation prepared by adopting calcitriol as raw material. The invention aims at making up the defects that the existing preparation formulation is little and the drug is not stable and providing an oral dripping pill preparation with high bioavailability, fast drug releasing, fast effect, high drug content, good stability of drug, convenient taking and no pollution in production. The calcitriol dripping pill adopts calcitriol as raw material and is prepared with carrier which is pharmaceutically acceptable and used as matrix.

The invention discloses a Chinese medicinal ointment, in particular a Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and a preparation method thereof. The Chinese medicinal ointment for treating the intervertebral disc hyperosteogeny is characterized by being prepared from the following components: Chinese angelica root, notopterygium, pubescent angelica root, clematis root, earthworm, suberect spatholobus stem, insects, white mustard seed, garter snake, drynaria, Chinese honeylocust spine, garden balsam stem, medicinal cyathula root, cassia twig, papaya, eucommia bark, divaricate saposhnikovia root, ephedra, acanthopanax bark, Chinese taxillus twig, pangolin scales, frankincense, myrrh, dragon's blood, musk and plum borneol. The Chinese medicinal ointment is specially used for treating the intervertebral disc hyperosteogeny, and by using the Chinese medicinal ointment, the concentration of the medicament applied into local tissues is significantly higher than the blood concentration, so the Chinese medicinal ointment is brought into full play, the local curative effect is obviously superior to internal treatment, and the Chinese medicinal ointment takes effect rapidly, has wide adaptation diseases, is safe to use, and has less toxic or side effect. 690 cases using the Chinese medicinal ointment for treatment show that the total effective rate reaches 96 percent.

The invention relates to a medicine used for treating knee osteoarthritis, and a preparation method thereof. The medicine used for treating knee osteoarthritis is prepared from raw materials of: 25 to 35g of variegated coralbean bark, 25 to 35g of speranskia tuberculata, 25 to 35g of Japanese clubmoss herb, 20 to 30g of slenderstyle acanthopanax root-bark, 20 to 30g of Chinese clematis root and rhizome, 20 to 30g of doubleteeth angelica root, 18 to 25g of raw common monkshood mother-root, 18 to 25g of raw kusnezoff monkshood mother-root, 15 to 20g of common burreed tuber, 10 to 15 parts of frankincense, 10 to 15g of myrrh, 20 to 25g of ligusticum, 25 to 25g of argy wormwood leaf, and 100 to 150ml of rice vinegar. According to the invention, a conservative therapy with an internal-disease external-treatment theory in Chinese medical science is adopted, and the pure traditional Chinese medicine preparation is adopted, such that surgery pains and costs of western medicine are reduced. The medicine provided by the invention is not absorbed by stomach, intestines, liver or kidney, such that no toxic or side-effect is brought to human bodies, and the occurrence of sequel is avoided. With the medicine, knee osteoarthritis is not easy to reoccur.

The invention discloses a new environment isolation configuration data management method and system. The method comprises the steps that initial configuration data used by a service system is input and/or changed at a configuration center background; a remote interface of a configuration data sever is called, and the initial configuration data is subjected to persistence to a database; after data persistence is completed, the configuration center background requests and receives nodes of the server in the service system, nodes except for the nodes of the server are informed, and meanwhile latest configuration data is synchronously obtained in the database. According to the method, system interaction is conducted based on an Http, configuration content is stored by means of an MYSQL database, and a distributed cluster forms multi-node deployment. In addition, configuration data timely perception, environment isolation and powerful disaster tolerance strategy are achieved.

The invention aims to provide a method, device and system for access control. According to the invention, acquisition of user equipment for access control information is controlled mainly through introducing access control activation indication to a base station end and a user equipment end, and then the user equipment is enabled to perform access control according to the acquired access control information. Compared with the prior art, a change notification mechanism for access control is enabled to take effect quickly and lose effectiveness smoothly, update and deactivation for the access control information at any time are support, the real-time performance of the acquired access control information is ensured by relying on specific equipment movements, and the workload of the user equipment for acquiring the access control information is reduced.

The invention provides a medicinal paste for treating Chinese honeylocust spine and hyperosteogeny and its preparing process, wherein the raw material herbs include the following constituents (by weight ratio): Chinese angelica root, Chinese ephedra, rhubarb horsetails, radix paeoniae rubrathe, dried rehmannia root, goldthread root, licorice root, thunberg fritillary bulb, honeysuckle flower, safflower, stem pith of the ricepapr plant, dahurian angelica root, radix aconiti. and the preparing process steps of cooling down the plaster and charging the following fine materials: pangolin scales, camphor, musk, boneol, frankincense, myrrh, and dragon's blood resin.

The indirubin dripping pill containing indirubin 1-12 mg and proper amount of dripping pill medium in each pill. The dripping pill medium is one or two of polyglycol-6000, polyglycol-4000, polyoxyethylene monostearate, sodium stearate, glycerin, gelatin, poloxamer, stearic acid, glycerin monostearate and insect wax. The preparation process of the indirubin dripping pill includes melting and mixing indirubin and dripping pill medium, dropping at 60-120 deg.c into condensating agent, and eliminating condensating agent. The condensating agent is one or two of dimethyl silicon oil, liquid paraffin, tea seed oil and rape seed oil. The indirubin dripping pill is dark red. The indirubin dripping pill is used in treating chronic granulocyte leukaemia, and has the features of less side effect, low dosage, high medicinal effect, no obvious inhibition on marrow of patient, etc.

The invention discloses an Epalrestat pill, which is characterized in that the invention comprises an Epalrestat, a Carmowax carrier, an antioxidant and a surfactant. The pill has favorable stability and high bioavailability.

The present invention discloses oral drip pill of sarcandra glaber and its preparation process. The oral drip pill has sarcandra glaber extractive as active components and proper amount of matrix. The matrix is polyglycol-6000, polyglycol-4000, polyethylene glycol monostearate, sodium stearate, glyceryl glutin, poloxamer, stearic acid, glyceryl monostearate, insect wax or their mixture. The preparation process includes decoction of sarcandra glaber, concentration, mixing the filtrate with alcohol via stirring, setting, concentration to obtain dry extractum, mixing with matrix while heatingto 60-100 deg.c, dripping into condensating agent, taking out, inspection and packing, with the condensating agent being dimethyl silicon oil, liquid paraffin, tea oil, rape seed oil, gasoline or their mixture.

The invention relates to a CDN prefix-based cache clearing system. The system comprises a data preprocessing module which has the functions of domain name prefix list extraction, refreshing and the like, a storage module which has a domain name list storage function, prefix refreshing task time and a caching time storage function, and a data analyzing processing module used for performing analyzing processing on file prefix data and obtaining a file from a source webpage once again. According to the CDN cache clearing method, a domain name maintaining prefix refreshing list is stored to each machine, and the time of a prefix refreshing task is recorded; for each file, the time when a file is cached is stored in meta data of the file; every time when a request arrives, whether or not a prefix refreshing list is hit is compared, if the prefix refreshing list is hit, the caching time of a file is queried, and if the refreshing time is latter than the caching time, the file is cleared anda previous level is returned to obtain the file once again; a full deletion mechanism is replaced with a marking function, and an action in which clearing is conducted according to prefixes can becomeeffective rapidly.

The present invention relates to one kind of slow released granular medicated diet for protecting gastrointestinal mucous membrane. The medicated diet is prepared with pearl, dark plum, Chinese yam, haw, malt and other seven kinds of Chinese medicinal materials in certain weight proportion. The medicated diet is used in treating gastrointestinal diseases and protecting gastrointestinal mucous membrane by means of its special affinity on gastrointestinal mucous membrane, and has the features of high effect and lasting action.

The present invention discloses anti-cold oral drip pill and its preparation process. The anti-cold oral drip pill has honeysuckle, red peony root and basket fern rhizome extractive as active components and proper amount of matrix. The matrix is polyglycol-6000, polyglycol-4000, polyethylene glycol monostearate, sodium stearate, glyceryl glutin, poloxamer, stearic acid, glyceryl monostearate, insect wax or their mixture. The preparation process includes twice decoction of honeysuckle, red peony root and basket fern rhizome, filtering, concentration, mixing the filtrate with alcohol via stirring, setting, filtering, concentration to obtain dry extractum, mixing with matrix while heating, dripping into condensating agent, taking out, inspection and packing, with the condensating agent beingdimethyl silicon oil, liquid paraffin, tea oil, rape seed oil, gasoline or their mixture.

The embodiment of the invention discloses an abnormal construction method and device for storage equipment, electronic equipment and a storage medium, and the method comprises the steps: responding tothe call of a tested program for a target rewriting operation function in a preloading library, and obtaining an exception parameter of the storage equipment; obtaining storage device abnormal operation information corresponding to a target rewriting operation function from the abnormal parameters; feeding back abnormal operation information of the storage device to the tested program; wherein the tested program is started based on a preloading library, the preloading library comprises a plurality of rewriting operation functions, and each rewriting operation function is obtained by rewritingbased on a storage device operation function of an application layer. The abnormal structure takes effect quickly, manual participation is not needed, limitation of equipment types is avoided, and the abnormal structure is accurate.

The invention relates to a body resistance strengthening and cough relieving traditional Chinese medicine. The body resistance strengthening and cough relieving traditional Chinese medicine is prepared from, by mass, 9-15 parts of cassia twig, 10-35 parts of Radix Astragali, 5-10 parts of white peony root, 5-10 parts of Manchurian wildginger, 5-15 parts of Chinese magnoliavine, 5-15 parts of Radix Platycodonis, 5-15 parts of processed pinellia tuber, 5-15 parts of apricot kernels, 5-15 parts of Radix Codonopsis, 5-15 parts of Rhizoma Atractylodis Macrocephalae, 5-15 parts of dried orange peel, 5-15 parts of dry ginger, 5-15 parts of jujubes, 5-15 parts of honey-fried licorice root, 10 parts of Blackberrylily Rhizome and 5-15 parts of Poria cocos. The traditional Chinese medicine has the advantages of rapid curative effect, mild mouthfeel, body resistance strengthening and pathogenicity removing effects, and no toxic or side effects, has the efficacy of warming the lung and lowering the adverse flow of qi, relieving coughs and preventing asthma, invigorating splenic yang and strengthening body resistance, and strengthening the spleen and reducing phlegm, and is especially suitable for coughs caused by colds, chili and consumptive disease, and acute and chronic bronchitis.

The invention discloses a Chinese medicinal plaster, in particular an externally applied medicament for a pediatric umbilical part and a preparation method thereof. The externally applied medicament for the pediatric umbilical part is characterized by being prepared from the following components: common burreed rhizome, curcuma zedoary, pangolin scales, medicine terminalia fruit, pepper, hawthorn, pharbitis seed, clove, Indian buead, medicinal evodia fruit, cinnamon, atractylodes rhizome, areca seed, oriental waterplantain rhizome, plantain seed, dried ginger, cuttlebone, radish seed, malt, amomum fruit, borneolum, musk and honey. The Chinese medicinal plaster is specially used for treating pediatric indigestion, diarrhea, anorexia, dyspepsia and malnutrition; the various medicaments are combined to activate qi, blood circulation and coronary circulation so as to fulfill the aim of tonification and purgation in combination; the plaster is safe in clinic application; medicament concentration in tissues of the umbilical part is obviously higher than blood concentration in the tissues of the umbilical part; therefore, the plaster is brought into full effect, the local curative effect is obviously superior to that of internal treatment, and the plaster has quick response, broad indication, is safe in use and has less toxic or side effect. 150 cases are treated in all, and the total effective rate reaches 96 percent.

The invention discloses a lactic acid levofloxacin dripping pills and its preparing process, wherein each drop pill contains Levofloxacin 1-10 mg and right amount of drop pill base material, the drop pill base material is selected from one or two of polyethylene glycol 6000, polyethylene glycol 4000, polyoxyethglene monostearate, sodium stearate, glycerol gelatine, poloxamer, stearic acid, glyceryl monostearate, insect wax. And the preparing process comprises the steps of heating till melting, mixing homogeneously, instilling into condensation agent, taking-up and removing the condensation agent, checking and packaging.

The invention discloses a traditional Chinese drug plaster, in particular to an umbilically applied drug for treating gynaopathy and a preparation method thereof. The drug is characterized by comprising the following components: frankincense, myrrh, dragon's blood, fructus cnidii, pale catechu, radix angelicae, realgar, borax, stalactite, musk, pepper, fennel, cassia twig, crocus sativus, rhizoma sparganii, curcuma zedoary, clove, asarum, pangolin, cinnamon, plum blossom borneol, semen brassicae and honey. The traditional Chinese drug plaster provided by the invention is specially used for treating the gynaopathy; the synergy of different medicines smoothes qi, dredges the artery and circulates the blood, thus achieving the purpos of tonification and purgation in combination and ensuring safe clinical application; the concentration of the drug applied in the local tissue of the umbilical region is obviously higher than the concentration of blood, thus giving full play to the functions; the local curative effect is obviously superior to the internal treatment; the drug takes effects rapidly, is suitable for wide diseases, and is safe in use and less in non-toxic side effect; and 162 patients has been treated, and the total efficiency reaches 96%.

The invention discloses a Chinese medical adhesive plaster, in particular discloses a medicine for umbilicus external use for treating hypertension and a preparation method thereof. The medicine for umbilicus external use for treating hypertension is characterized by comprising the following components: gastrodia elata, uncaria, peach kernel, red peony root, saffron, rhizoma sparganii, zedoary turmeric, savia miltiorrhiza, leech, ligusticum wallichii, cassia seed, nacre mother of pearl, cortex moutan, chrysanthemum, oyster, radix scutellariae, gardenia, radish seed, hawthorn, cinnamon, borneol, muskiness and honey. The Chinese medical adhesive plaster of the invention is specially used for treating hypertension, the components cooperate to tonify qi and activate blood to promote pulses, and therefore, the purpose of reinforcement and elimination in combination is achieved. The Chinese medical adhesive plaster is safe for clinical application, the concentration of the medicine applied into umbilical local tissues is significantly higher than blood concentration, therefore, the medicine plays a better role, local curative effect is significantly better than that of internal treatment, and the medicine is fast to take effects, suitable for many symptoms and safe for use, and has few toxic and side effects. The medicine is used for treatment in 131 cases altogether, and the whole effective rate reaches 98%.